Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilretta for Prevention of PTOA After ACL and Meniscus Injury
NCT04331002Phase 2Terminated
- Start
- Aug 2020
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in Post-traumatic osteoarthritis (PTOA). Started Aug 2020; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT04331002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331002.